Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2007-07-10
2007-07-10
Hui, San-Ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
active
09794531
ABSTRACT:
The present invention relates to the field of cancer, and in particular hormone dependent cancers including, but not limited to prostate, breast, endometrial, ovarian, thyroid, bone, and testis. The present invention also relates to the use of steroid analogues, and in particular analogues of Δ5-androstene-3-β, 17α-diol, and its epimer Δ5-androstene-3-β, 17β-diol for the treatment and prevention of cancer.
REFERENCES:
patent: 4628052 (1986-12-01), Peat
patent: 4898694 (1990-02-01), Schwartz et al.
patent: 5001119 (1991-03-01), Schwartz et al.
patent: 5028631 (1991-07-01), Schwartz et al.
patent: 5206008 (1993-04-01), Loria
patent: 5387583 (1995-02-01), Loria
patent: 5461042 (1995-10-01), Loria
patent: 5527789 (1996-06-01), Nyce
patent: 5641768 (1997-06-01), Loria
patent: 5714481 (1998-02-01), Schwartz et al.
patent: 5744462 (1998-04-01), Schwartz et al.
patent: 5763433 (1998-06-01), Morfin
patent: 5776923 (1998-07-01), Labrie
patent: 5798347 (1998-08-01), Labrie
patent: 5837269 (1998-11-01), Daynes et al.
patent: 5861387 (1999-01-01), Labrie
patent: 5912240 (1999-06-01), Loria
patent: 5922728 (1999-07-01), Panzeri et al.
patent: 6110906 (2000-08-01), Labrie et al.
patent: WO 94/23722 (1994-10-01), None
patent: WO 95/10527 (1995-04-01), None
patent: WO97/37662 (1997-10-01), None
patent: WO 97/37662 (1997-10-01), None
patent: WO 98/31371 (1998-07-01), None
patent: WO 99/63973 (1999-12-01), None
patent: WO 99/63974 (1999-12-01), None
patent: WO 00/56757 (2000-09-01), None
patent: WO 01/23405 (2001-04-01), None
Berkow, Merck manual of Diagnosis and Therapy, 1992, 16thedition, p. 1750-1751.
Rozhin et al., “Endocrine Steriod Sulfotransferases: Steriod Alcohol Sulfotransferase From Human Breat Carcinoma Cell Line MCF-7,”J. Steriod Biochem., 1986, pp. 973-979, vol. 25, No. 6.
Pasqualini, “Role of Androgens in Breast Cancer,”J. Steriod Biochem. Molec. Biol., 1993, pp. 167-172, vol. 45, Nos. 1-3.
Hui San-Ming
Muenchau Daryl D.
LandOfFree
Method of treatment of prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment of prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of prostate cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3776292